Hepatitis C Virus NS3/4A Protease Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 2212-4071|3|3|157-167

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.3, Iss.3, 2008-11, pp. : 157-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor

By Love R.A.   Parge H.E.   Wickersham J.A.   Hostomsky Z.   Habuka N.   Moomaw E.W.   Adachi T.   Margosiak S.   Dagostino E.   Hostomska Z.  

Clinical and Diagnostic Virology, Vol. 10, Iss. 2, 1998-07 ,pp. : 151-156

Elsevier

Access to resources Recommend Favorite

Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection

By Chu C.-M.   Sheen I.-S.   Liaw Y.-F.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 8, 2004-08 ,pp. : 778-782

Informa Healthcare

Access to resources Recommend Favorite

Septic Bursitis, a Potential Complication of Protease Inhibitor Use in Hepatitis C Virus

By Burke Caitlin C.   Martel-Laferriere Valerie   Dieterich Douglas T.  

Clinical Infectious Diseases, Vol. 56, Iss. 10, 2013-05 ,pp. : 1507-1508

Oxford University Press

Access to resources Recommend Favorite

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance

By Gale J.   Korth M.J.   Katze M.G.  

Clinical and Diagnostic Virology, Vol. 10, Iss. 2, 1998-07 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite

Protease inhibitors for treatment of chronic hepatitis C-a new target for the magic bullet identified

By Ferenci P.  

Journal of Hepatology, Vol. 40, Iss. 1, 2004-01 ,pp. : 184-186

Elsevier

Access to resources Recommend Favorite